- Study Protocol
- Open Access
- Open Peer Review
Development and feasibility testing of an intervention to support active lifestyles in youths with type 1 diabetes—the ActivPals programme: a study protocol
© The Author(s). 2016
- Received: 31 May 2016
- Accepted: 20 October 2016
- Published: 8 November 2016
The global incidence of type 1 diabetes is rising, and youths with type 1 diabetes continue to suffer poorer health than peers without diabetes. Evidence suggests youths with type 1 diabetes have physical activity (PA) levels well below the recommendations for health and have high levels of sedentary behaviour. An active lifestyle is therefore recommended to improve health. There is limited research showing effective lifestyle behaviour change in this population; therefore, an evidence gap exists between the need to promote physical activity in type 1 diabetes care and lack of understanding on how to do this. This protocol paper describes a feasibility and pilot study of the ActivPals programme—an intervention to support active lifestyles in youths with type 1 diabetes.
Key intervention components have been identified from preliminary work (individual and family focus, peer mentoring, technology integration and improved communication and understanding) and are being developed into a pragmatic randomised controlled trial (RCT) supported by recruitment pathways. A steering group of health care professionals and managers will refine the intervention to patient needs. A pilot trial is providing data on intervention implementation, acceptability and feasibility. Twenty youths with type 1 diabetes are being recruited and randomised into an intervention or control group. Physical activity is being measured objectively using the Actigraph GT3X+ monitor at baseline and 1-month follow-up. Contextual factors associated with intervention delivery are being explored.
This study will contribute to the development of evidence-based, user-informed and pragmatic interventions leading to healthier lifestyles in youths with type 1 diabetes.
- Type 1 diabetes
- Physical activity
Type 1 diabetes is a chronic disease where the insulin-producing pancreatic beta cells are destroyed resulting in an inability of the body to regulate blood glucose. The condition is managed by regular monitoring of blood glucose, administering insulin and participating in a healthy diet and regular physical activity . Diabetes has been a growing public health burden across the world  with treatment for type 1 diabetes costing the NHS in England roughly £1.802 billion a year . The global incidence of type 1 diabetes is rising with an estimated 70 % rise in the disease by 2020, in European adolescents under age 15 . Despite significant improvements in technology for blood glucose management, youths with type 1 diabetes continue to suffer from poorer health, relative to peers without diabetes. For example, research suggests there are higher mortality rates, more cardiovascular risk factors, higher rates of depression, lower educational attainment and poorer psychosocial health outcomes [5, 6].
Glycosylated haemoglobin (HbA1c) is a measure of glycaemic control and is considered by both patients and health care professionals to be at the core of type 1 diabetes management . HbA1c is an important marker for risk of developing micro- or macrovascular complications of diabetes (such as retinopathy, nephropathy, cardiovascular disease and cerebrovascular disease) . Diabetic complications develop as a result of chronic hyperglycaemia which causes damage to tissues and can develop as early as 2 years from diagnosis . Improving HbA1c is therefore a priority for youths with type 1 diabetes.
There is now a small body of evidence which suggests regular physical activity (PA) can significantly reduce HbA1c levels in individuals with type 1 diabetes [7, 10, 11]. This builds on the prolific evidence showing the positive physical and psychological benefits of regular PA in childhood and adolescence . Regular physical activity is therefore recommended in clinical guidelines as one of the core elements of good type 1 diabetes management . Despite appreciation for the benefits of physical activity, evidence suggests youths with type 1 diabetes are less physically active than peers without diabetes [14–16]. For example, a recent study  found that young people with type 1 diabetes aged 7–9 and 12–14 years spent on average 78 % (10.2 h/day) of the waking day sedentary and 43 min/day participating in moderate to vigorous PA. Sedentary behaviour is a distinct class of behaviours (i.e. sitting, watching television, playing video games) that is characterised by little physical movement and low energy expenditure . Only two of the 40 participants in the study achieved minimum guidelines of PA participation of 60 min moderate to vigorous intensity PA (MVPA) on each accelerometer wear day, and 19/40 did not achieve 60 min of MVPA on any day. As PA levels are well below the recommendations for health and sedentary behaviour is high in youths with type 1 diabetes, there is clearly a need for intervention studies to support this population to lead an active lifestyle.
Whilst there have been a variety of published intervention studies with youths with type 1 diabetes, there are limitations with this work. For example, interventions have not been based on behavioural change theories [10, 18], have uncontrolled designs [19, 20], or consist of a very structured supervised intervention design (e.g. using supervised structured exercise classes in the intervention) [20–24]. Whilst short-term changes in PA might be evident with such supervised settings, often, the PA behaviour reverts back to pre-intervention levels when the supervised intervention is removed . No study has been conducted, to our knowledge, which is theoretically based, adopts a randomised controlled design and has been tailored to young people and families with type 1 diabetes to support long-term lifestyle behaviour change. As such, there is a need for new, higher quality (evidence informed and theoretically based) interventions, which are developed using the UK Medical Research Council (MRC) framework .
An intervention (ActivPals programme) to support active lifestyles in youths with type 1 diabetes
Feasible recruitment pathways towards the intervention
Importantly, the intervention and recruitment pathways will be evidence based whilst being pragmatic and suitable for integration within current type 1 diabetes NHS practice.
The recruitment, initial retention and adherence level that can be achieved for a 4-week intervention programme in both the intervention and control groups.
Preliminary evidence of effects of the intervention on physical activity, sedentary behaviour and quality of life. This will provide a preliminary indication of whether the intervention can show change within this group. Following this, an effect size will be estimated for a ‘definitive’ randomised controlled trial.
The acceptability of the intervention recruitment pathways and intervention content, delivery, duration and intensity to participants and health professionals.
Aged between 7 and 16 who have a medical diagnosis of type 1 diabetes (a medical professional will have previously tested glycated haemoglobin (HbA1c) levels and provided a diagnosis)
Are registered in Greater Glasgow and Clyde Children’s Diabetes Service
Are independently ambulatory
Been advised not to undertake physical activity by their doctor
Severe learning disabilities and not able to understand the study protocol
Severe challenging behaviour or other needs requiring constant one to one support
Researchers have identified the need for a recruitment strategy in RCTs [27, 28]. A strategy has been designed to guide the recruitment process. The full strategy is shown in Appendix. Participants will be recruited to phase 2 via three recruitment points: (1) from paediatric diabetes clinics (main recruitment site), (2) through support groups or clubs for young people with type 1 diabetes and (3) the diabetes nurses working at the hospital will screen the medical records of paediatric patients registered at the clinic for eligibility to participate in the study. To ensure patient confidentiality, clinic staff will screen the patient records and only retrieve information on participant’s age, any exclusion criteria and next appointment date. The staff and researcher will not discuss any information on patient files. The researchers will assess the most effective recruitment routes which will inform future work with this population. There are three type 1 diabetes clinics per week at Yorkhill hospital (the main recruitment site) and others across Greater Glasgow and Clyde paediatric diabetes service. Greater Glasgow and Clyde is the largest urban area in Scotland and the fifth largest in the United Kingdom (UK) , therefore offering a fairly representative sample of young people living in urban areas in the UK. Participants who attend a paediatric diabetes clinic and meet the inclusion criteria will be informed of the study by the researcher or by the paediatric consultant, diabetes doctors and nurses. Those who are eligible and interested in participating in the study will be given an information pack which will include more details about participation. Participants can express interest in the study by signing and returning a tear-off slip in the information pack and posting it using the self-addressed envelope provided. The researcher will then contact participants and arrange a visit to discuss the study. A strong collaboration between the research group and the diabetes health care team has already been established based on previous research carried out with this population [10, 16].
Consent and randomisation
Participants who are interested and eligible to participate will be randomised individually to the intervention or control group. As this is a small-scale feasibility and pilot study, the researcher collecting the data will also deliver the intervention. Therefore, it is not possible for the researcher to be blind from the treatment group. Another member of the research team (the PI) will randomise participants and write the treatment allocation for each participant on a piece of paper. This will be placed in a sealed envelope, only to be opened by the researcher immediately before the intervention/control group visit. Consent/assent will be sought at two stages: firstly, for permission from the carer to be contacted by the researcher to arrange appointments and, secondly, written consent/assent to opt into participate in each aspect of the study (physical activity intervention component and interview component). This will be sought at the study visits, once the researcher has discussed the study in detail with participants. Written information sheets will be given to participants (young people and parents/carers). The researcher will go over the information sheet with participants at the first visit to ensure that participants understand the study protocol and what is being asked of them.
Withdrawal of study participants
The participants will be given every opportunity to clarify points they do not understand and, if necessary, ask for more information. Participants will be given sufficient time to consider the information sheets provided. It will be emphasised that the participant may withdraw their consent to participate at any time without loss of benefits to which they otherwise would be entitled. Participants will only be withdrawn from the study by the researcher if the researcher perceives them to be at risk or if there is a serious adverse event. If there is a serious adverse event (e.g. injury from exercise, medical help sought for diabetes), the details of this will be recorded on a Serious Adverse Event form, provided by the local NHS board and national good clinical practice will be followed. The researchers will monitor any adverse events during the study.
Support youths with type 1 diabetes to initiate and maintain an active lifestyle, including increased MVPA and reduced sedentary behaviour
Be endorsed by NHS diabetes care staff highlighting a clear integration of physical activity into diabetes care and be of a duration and intensity realistic for roll out in practice
Phase 1 (4 months): aim—development of intervention and recruitment pathways
The researchers have identified the key components of the intervention that will be developed and piloted based on prior work with this population. A steering group of diabetes health care professionals and individuals at management level will be established, using the James Lind Alliance framework. The steering group will advise on how these key components are implemented and will assist with refining the intervention. The steering group will help to guide the intervention to the needs of patients, tailor intervention delivery within current clinical practice and support dissemination to a broader audience of patients and diabetes educators.
Physical activity consultation
Role modelling/peer mentors
Often, group structured education sessions are offered as part of diabetes care. Group/peer support has been identified as an important component of an intervention to support active lifestyles in our previous research [10, 16]. During the development of the ActivPals intervention, we will explore how the intervention could be integrated with current diabetes group education sessions. In particular, group sessions offer an opportunity to incorporate peer support, involving sharing experiences, mentoring and role-modelling. The suitability and feasibility of including peer support within group educations will be explored during intervention development. In addition, the inclusion of role models/peer mentors will be examined. Peer mentors will be athletes with type 1diabetes identified by the researchers. Motivational videos will be provided as part of the intervention, which will contain information about the benefits of physical activity participation, particularly when living with type 1 diabetes. Participants will be given the link to the ‘YouTube’ videos and encouraged to watch these regularly in their own time, over the intervention period, to increase PA.
Continued support through social media/emails or telephone contact
We will explore the possible use of social media, emailing or telephone support as a mechanism for continued support and to provide further information on aspects of diabetes management.
Phase 2 (8 months): aim—feasibility trial
Once the ActivPals intervention has been developed, we will conduct a feasibility study to explore intervention feasibility and test practical aspects of study design. Based on previous literature, an effect size will be estimated for a subsequent definitive randomised controlled trial.
Participants (child and parent/carer) will be visited a minimum of four times during this pilot study. During visit 1, basic demographic (gender, age), medical information (body mass index, diabetes duration and current therapy), PA and QoL questionnaires (see primary and secondary outcome measures section) will be completed and participants will be given an Actigraph activity monitor and asked to wear this for the next 7 days. An accelerometer wear diary will be given to participants to record attachment and removal.
Visit 2 will occur approximately 8 days later. At this point, activity monitors and wear diaries will be returned and participants will then be randomised into the intervention or control group. At this point, the researcher will open the envelope to reveal the treatment group. Those who have been allocated to the intervention arm of the study will receive the PA consultation and intervention materials. The intervention period will last 4 weeks, after which visit 3 will take place. During this visit, both intervention and control participants will once again be given an Actigraph activity monitor and asked to wear this for the next 7 days. An accelerometer wear diary will again be given to participants to record attachment and removal. Visit 4 will occur approximately 8 days later during which time activity monitors and wear diaries will be returned. Participants will be asked to complete the PA and QoL questionnaires with the researcher. Intervention participants will be invited to participate in a short interview to explore views on the ActivPals intervention programme. At this point, participants in the control group will be offered the physical activity intervention, followed by an interview. A wait list control design will be used as it would be unethical to deny participants’ access to an intervention which we believe is likely to be beneficial to health. See Fig. 3 for study flow chart. More details on the pilot study design are noted below following the PICOT protocol (e.g. Population, Intervention, Comparison group, Outcome measures (feasibility and patient centred) and Timing).
See the ‘Study population’ section.
The ActivPals intervention programme will be developed during phase 1.
The comparison group will receive standard diabetes care. Control participants will be offered the intervention after they have completed follow-up outcome measures.
Feasibility outcome measures
We will monitor the feasibility of the trial by tracking recruitment, retention and adherence rates of participants and the most effective points of recruitment. In addition, feedback about the delivery of the intervention, intervention content and perceived impact will all be explored through the qualitative interviews with participants and parents, carried out at the end of the study. The researchers will also meet with the steering group at the end of the study to feedback the results and discuss intervention acceptability.
Patient-centred outcome measures
Objective measures of physical activity and sedentary behaviour will be collected using the Actigraph GT3X+ monitor. This monitor will allow objective recording of daily time spent in sedentary, light and moderate to vigorous physical activity. These monitors are small (approx size of a 2-pound coin) and lightweight (19 g). Participants will be asked to wear the accelerometers around the waist during waking hours for 7 days, excluding water-based activities. Accelerometer data will be downloaded to Actilife software (version 6.4.3). In line with previous studies, a minimum wear time for a valid day will be defined as 6 h/day, with 3 days of data required for analysis inclusion [33, 34].
The primary outcome measure of daily time spent in MVPA and sedentary behaviour will be determined using cut-points calibrated and validated in paediatric studies: sedentary (<100 cpm)  and MVPA (≥3200 cpm) . In addition to the accelerometer data, information will be gathered about the type, frequency and location (e.g. school) of activities undertaken in the last 7 days. This information will be collected from participants with the help of their parent/cares at baseline and follow-up (post-intervention/control). This questionnaire will be developed based on the findings of a previously conducted survey study .
Generic and disease-specific questionnaires will be used to measure quality of life in participants. The PedsQoL 4.0 Generic Core Scale was used to measure general quality of life . This 23-item questionnaire contains the following subscales: physical functioning, emotional functioning, social functioning and school functioning. A psychosocial health summary score will be calculated from the average of the emotional, social and school functioning subscales, a physical health summary score (from the physical functioning subscale) and a total overall score from the average of all subscales. This scale has shown good reliability and validity in this population [38, 39]. The PedsQoL 3.0 type 1 Diabetes Module is a 28-item questionnaire measuring diabetes-specific QoL consists of five subscales: diabetes symptoms, treatment barriers, treatment adherence, worry and communication. Patients (self-report) and their parents (proxy-report of the child’s QoL) will complete questionnaires by rating items on how much each was a problem in the previous month using a 5-point Likert scale (‘0’ = never a problem; ‘4’ = almost always a problem). This questionnaire has been validated and has shown to be reliable in children with type 1 diabetes [38, 40]. Changes in general QoL and diabetes module scores will be analysed between intervention and control groups to asses for any trends in intervention effects.
We will also determine key process-related outcomes including intervention recruitment, retention and compliance. As mentioned, a qualitative interview will be carried out post-intervention to determine contextual factors associated with delivery of the intervention and to explore patient and health professional experiences of the ActivPals programme including acceptability of procedures, perceived benefits and difficulties. According to the MRC framework , qualitative research can be valuable for identifying what the important or ‘active ingredients’ of an intervention are and which elements are not related to the ‘treatment effect’. Topics which will be covered include perceptions of project, sport and PA participation, views on intervention components, attitudes towards PA, benefits and barriers towards PA and sustainability of PA. A parent is encouraged to participate in the interview. With the participant’s permission, the interviews will be recorded and transcribed. Otherwise, notes taken during the interview will be written up in detail as soon as possible afterwards. Interviews will be analysed by thematic analysis. Feasibility and acceptability measures will be reported including programme implementation and fidelity to protocol.
The measures will give an indication of the effects of the intervention on PA levels, sedentary behaviour and quality of life. The acceptability of the measures and missing data will be considered when designing the full-scale trial.
Outcome measures will be assessed at baseline (before intervention) and 1 month after the initial physical activity consultation appointment.
This pilot RCT will be performed according to the Research Governance Framework for Health and Community Care (second edition, 2006).
Statistics and data analysis
Descriptive statistics will be presented (mean and standard deviation) with 95 % confidence intervals presented for each group separately. Changes in physical activity and QoL from baseline and follow-up will be assessed using an ANOVA. As this is a feasibility and pilot study, the study will be underpowered; therefore, quantitative outcomes will be interpreted only as feasibility and pilot data.
This paper describes the ActivPals study aims and design, including information about the intervention, the outcome measures and recruitment process. Whilst there is a strong evidence base which suggests that regular PA can have a range of physical and psychological benefits for youths with type 1 diabetes, an evidence gap exists between the need to promote long-term lifestyle physical activity in type 1 diabetes care and lack of understanding on how to do this. A vital first step in developing this field is development and piloting a theoretically based, pragmatic, lifestyle intervention for youths with type 1 diabetes.
Limitations of the research
As this is a small-scale pilot and feasibility study, the researcher (first author) will be recruiting participants, collecting the data and also delivering the intervention. Whilst we acknowledge that a double-blind pilot RCT would strengthen the design of the study, there is limited time and resource with this small-scale pilot study. Therefore, any future funding applications to test the effectiveness of the intervention would include costs for a health professional and research assistant to avoid potential biases in the trial design. Researcher bias will be reduced in the qualitative element of the study as an MSc student, independent to the study, will be conducting the interviews.
The time and funding limitations also restrict the possibility of collecting post-intervention/control follow-up data. Thus, it is not possible to assess long-term effects of the intervention in this small pilot study. These limitations will be addressed in the next phase of work.
As the aim of the intervention is to increase physical activity levels, changes to lifestyle are encouraged. There is unlikely to be any pain or discomfort associated with increased physical activity. Participants will be advised to carry out prescribed stretches before and after the activity to minimise any muscle stiffness resulting from exercise. These will be described in detail by the researcher when delivering the intervention. Increased exercise can cause hypoglycaemia in those with type 1 diabetes, if they are experiencing low blood sugar levels. Participants will therefore be asked to monitor blood sugar levels before and during exercising, and post exercise, to minimise the risk of this occurring. Participants will follow Greater Glasgow and Clyde children’s diabetes service exercise guidelines, which will be included in the intervention information books for parents and young people with type 1 diabetes (intervention resources). The researcher will talk participants through this information during the PA consultation. The intervention will be individualised to each participant’s baseline level of activity; therefore, the activity will begin at a level that is comfortable and achievable. Activity intensity, frequency and duration will increase progressively over time. The intervention will be designed by experts working in the physical activity and diabetes field who have experience of advising on appropriate levels and intensity of activity. At the end of the study, the resources will be integrated with current routine care for type 1diabetes (i.e. these will be offered to all patients when they are visiting clinic). Participants will also be given information about support networks and other diabetes care team members they can speak to about increasing physical activity.
Strengths of the research
A key strength of this study is that it aligns with the development and feasibility stage of the MRC framework for the development of complex health interventions. The findings from this feasibility and pilot study will generate output critical to the subsequent stage of the MRC framework which is the development and running of a definitive trial exploring the effectiveness of physical activity and sedentary behaviour intervention within type 1 diabetes care (see Fig. 1). Specific output from phase 1 will be a new evidence-based, pragmatic and user-informed intervention and suitable recruitment pathways to support active lifestyles for youths with type 1 diabetes. Specific output from phase 2 will be an important information on recruitment, initial retention and the adherence level that can be achieved for a 4-week intervention in both the intervention and control groups. In addition, indicative effect of the intervention on physical activity and sedentary behaviour will be important for the definitive trial. Acceptability of the intervention, recruitment pathways and intervention content, delivery, duration, intensity to participants and health professionals will also be explored. The study will therefore lead to new knowledge of direct relevance to the NHS for improving physical activity both in diabetes care and in the care of youths with other chronic conditions. Importantly, the qualitative interviews will provide information about context of young people with type 1 diabetes lives and will also allow us to understand experiences, attitudes, perceptions and behaviours following completion of the ActivPals PA intervention. This exploratory work will be instrumental in designing and developing a full-scale trial to test the effectiveness of the intervention.
The study is currently under way. All participants were recruited from January to March 2016. Results of the study will be submitted for publication from January 2017.
We would like to thank Yorkhill Children’s Charity for funding this research.
AK is the PI of the study and designed the protocol. FM drafted the protocol paper. All authors contributed to redrafting and editing of the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Ethics approval and consent to participate
The study will be carried out in accordance with the World Medical Association Declaration of Helsinki (1964) and its revisions (Tokyo (1975), Venice (1983), Hong Kong (1989), Somerset West (1996), Edinburgh (2000), Washington DC (2002), Tokyo (2004), Seoul (2008), Fortaleza (2013)). Favourable ethical opinion has been sought from an appropriate REC. Patients will only be allowed to enter the study once they have provided written informed consent or their next of kin have provided written informed consent.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med. 1994;331:1428–36.View ArticlePubMedGoogle Scholar
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53. doi:10.2337/diacare.27.5.1047.View ArticlePubMedGoogle Scholar
- Kanavos P, van den Aardweg S, Schurer W. Diabetes expenditure, burden of disease and management in 5 EU countries. London: London school of economics; 2012.Google Scholar
- Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-2020: a multicentre prospective registration study. Lancet. 2009;373:2027–33.View ArticlePubMedGoogle Scholar
- Kalyva E, Malakonaki E, Eiser C, Mamoulakis D. Health related quality of life (HrQoL) of children with type 1 diabetes mellitus (T1DM): self and parental perceptions. Pediatr Diabetes. 2011;12:34–40.View ArticlePubMedGoogle Scholar
- Wennick A, Hallström I, Lindgren B, Bolin K. Attained education and self-assessed health later in life when diagnosed with diabetes in childhood: a population-based study. Pediatr Diabetes. 2011;12(7):619–26.View ArticlePubMedGoogle Scholar
- Kennedy A, Nirantharakumar K, Chimen M, Pang TT, Hemming K, Andrews RC, et al. Does exercise improve glycaemic control in type 1 diabetes? A systematic review and meta-analysis. PLoS One. 2013;8:3.Google Scholar
- Kilpatrick ES. The rise and fall of HbA1c as a risk marker for diabetes complications. Diabetologia. 2012;55(8):2089–91. doi:10.1007/s00125-012-2610-5.View ArticlePubMedGoogle Scholar
- Cho YH, Hing S, Craig ME, et al. Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes. Pediatr Diabetes. 2011;12:682–9.View ArticlePubMedGoogle Scholar
- MacMillan F, Kirk A, Mutrie N, Matthews L, Robertson K, Saunders DH. A systematic review of physical activity and sedentary behavior intervention studies in youths with type 1 diabetes: study characteristics, intervention design, and efficacy. Pediatr Diabetes. 2014;15(3):175–89. doi:10.1111/pedi.12060.View ArticlePubMedGoogle Scholar
- Quirk H, Blake H, Tennyson R, Randell TL, Glazebrook C. Physical activity interventions in children and young people with type 1 diabetes mellitus: a systematic review with meta-analysis. Diabet Med. 2014;31(10):1163–73. doi:10.1111/dme.12531.View ArticlePubMedPubMed CentralGoogle Scholar
- WHO. Global recommendations on physical activity for health. Geneva: World Health Organization; 2010.Google Scholar
- Robertson K AP, Scheiner G, Hanas R, Riddell M. ISPAD clinical practice consensus guidelines 2014 compendium: exercise in children and adolescents with diabetes. Pediatr Diabetes. 2014;9(1):65-77.Google Scholar
- Maggio A, Hofer MF, Martin X, Marchand L, Beghetti M, Farpour-Lambert N. Reduced physical activity level and cardiorespiratory fitness in children with chronic diseases. Eur J Pediatr. 2010;169:1187–93.View ArticlePubMedGoogle Scholar
- Valerio G, Spagnuolo M, Lombardi F, Spadaro R, Siano M, Franzese A. Physical activity and sports participation in children and adolescents with type 1 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2007;17(5):376–82.View ArticlePubMedGoogle Scholar
- MacMillan F, Kirk A, Mutrie N, Robertson K. Physical activity and sedentary behaviour in Scottish youths with type 1 diabetes. Pract Diabetes. 2014;31(6):228c–33. doi:10.1002/pdi.1874.View ArticleGoogle Scholar
- Tremblay M, LeBlanc A, Janssen I, Kho M, Hicks A, Murumets K, Colley R, Duggan M. Canadian sedentary behaviour guidelines for children and youths. Appl Physiol Nutr Metab. 2011;36:59–64.View ArticlePubMedGoogle Scholar
- Newton KH, Wiltshire EJ, Elley CR. Pedometers and text messaging to increase physical activity randomized controlled trial of adolescents with type 1 diabetes. Diabetes Care. 2009;32:813–5.View ArticlePubMedPubMed CentralGoogle Scholar
- Faulkner M, Fleet S, Hepworth J. A personalized approach to exercise promotion in adolescents with type 1 diabetes. Pediatr Diabetes. 2010;11:166–74.View ArticlePubMedGoogle Scholar
- Mosher PE, Nash MS, Perry AC, LaPerriere AR, Goldberg RB. Aerobic circuit exercise training: effect on adolescents with well-controlled insulin-dependent diabetes mellitus. Arch Phys Med Rehabil. 1998;79:652–7.View ArticlePubMedGoogle Scholar
- Tunar M, Ozen S, Goksen D, Asar G, Bediz CS, Darcan S. The effects of Pilates on metabolic control and physical performance in adolescents with type 1 diabetes mellitus. J Diabetes Complications. 2012;26:348–51.View ArticlePubMedGoogle Scholar
- Salem M, AboElAsrar MA, Elbarbary N, ElHilaly R, Refaat Y. Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial. Diabetol Metab Syndr. 2010;2:47.View ArticlePubMedPubMed CentralGoogle Scholar
- Aouadi RKR, Aouidet A, Ben MA, Ben RM, Mdini F, et al. Aerobic training programs and glycemic control in diabetic children in relation to exercise frequency. J Sports Med Phys Fitness. 2011;51:393.PubMedGoogle Scholar
- Stratton R, Wilson DP, Endres RK, Goldstein DE. Improved glycemic control after supervised 8-wk exercise program in insulin-dependent diabetic adolescents. Diabetes Care. 1987;10:589–93.View ArticlePubMedGoogle Scholar
- Biddle S, Mutire N, Gorley T. Psychology of physical activity. 3rd ed. Oxon: Routledge; 2015.Google Scholar
- Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. Br Med J. 2008;337:a1655.Google Scholar
- Foster C, Brennan G, Matthews A, McAdam C, Fitzsimons C, Mutrie N. Recruiting participants to walking intervention studies: a systematic review. Int J Behav Nutr Phys Act. 2011;8:137. doi:10.1136/bmj.a1655.
- Treweek S, Mitchell E, Pitkethly M, Cook J, Kjeldstrom M, Taskila T, et al. Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev. 2010;1:1–106.Google Scholar
- Statistics OfN. The UK’s major urban areas. 2005.Google Scholar
- Bandura A. Social foundations of thought and action: a social cognitive theory. New Jersey: Prentice-Hall; 1986.Google Scholar
- Simmons D. Peer support: time to tap the (largely) untapped. Pract Diabetes. 2013;30:246–50.View ArticleGoogle Scholar
- Kirk A, Barnett J, Mutrie N. Physical activity consultation for people with type 2 diabetes. Evidence and guidelines. Diabet Med. 2007;8:809–16.View ArticleGoogle Scholar
- Janssen X, Basterfield L, Parkinson K, Pearce M, Reilly J, Adamson A, Reilly J. Objective measurement of sedentary behaviour: impact of non-wear time rules on changes in sedentary time. BMC Public Health. 2015;15:504.View ArticlePubMedPubMed CentralGoogle Scholar
- Basterfield L, Adamson AJ, Pearce MS, Reilly JJ. Stability of habitual physical activity and sedentary behaviour monitoring by accelorometry in 6 to 8 year olds. J Phys Act Health. 2011;8:543–7.View ArticlePubMedGoogle Scholar
- Evenson KR, Catellier DJ, Karminder G, Ondrak KS, McMurray RG. Calibration of two objective measures of physical activity for children. J Sports Sci. 2008;24(14):1557–65.View ArticleGoogle Scholar
- Puyau MR, Adolph AL, Vohra FA, Butte NF. Validation and calibration of physical activity monitors in children. Obes Res. 2002;10(3):150–7.View ArticlePubMedGoogle Scholar
- Woods CB, Moyna N, Quinlan A, Tannehill D, Walsh J. The children’s sport participation and physical activity study (CSPPA study): research report no 1. Dublin: Dublin City University and The Irish Sports Council; 2010.Google Scholar
- Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL. The PedsQL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Type 1 Diabetes Module. Diabetes Care. 2003;26(3):631–7.View ArticlePubMedGoogle Scholar
- Upton P, et al. Measurement properties of the UK-English version of the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales. Health Qual Life Outcomes. 2005;3:2.View ArticleGoogle Scholar
- Sand P, et al. The reliability of the health related quality of life questionnaire PedsQL 3.0 Diabetes ModuleTM for Swedish children with type 1 diabetes. Acta Paediatr. 2012;101(8):e344–9.View ArticlePubMedGoogle Scholar
- Boyle A, Melville CA, Morrison J, Allan L, Smiley E, Espie CA, et al. A cohort study of the prevalence of sleep problems in adults with intellectual disabilities. J Sleep Res. 2010;19(1-Part-I):42–53. doi:10.1111/j.1365-2869.2009.00788.x.View ArticlePubMedGoogle Scholar